Figure 1 (Ef3792bb 0d03 450c B4fa 53fbaae49bd5 01)
Bromfenac Solution/ Drops
Product Images NDC 68180-434
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Bromfenac (NDC 68180-434). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure A (Ef3792bb 0d03 450c B4fa 53fbaae49bd5 02)
This is a tamper-evident security feature showing a ring that is intact and a ring that is broken. This feature helps to indicate if a product has been opened or tampered with. The provided text appears to be part of an illustration or diagram labeled as "Figure A".*
Figure B (Ef3792bb 0d03 450c B4fa 53fbaae49bd5 03)
Figure C (Ef3792bb 0d03 450c B4fa 53fbaae49bd5 04)
Figure D (Ef3792bb 0d03 450c B4fa 53fbaae49bd5 05)
Figure E (Ef3792bb 0d03 450c B4fa 53fbaae49bd5 06)
Figure F (Ef3792bb 0d03 450c B4fa 53fbaae49bd5 07)
Figure G (Ef3792bb 0d03 450c B4fa 53fbaae49bd5 08)
Figure 6 (Ef3792bb 0d03 450c B4fa 53fbaae49bd5 09)
This is a prescription ophthalmic solution containing Bromfenac for topical application on the eye. Each mL of the solution includes sodium sesquihydrate (0.883%) and bromfenac (0.075%). The label indicates that this product is for prescription use only and should be used as directed. Lot and expiration information are to be printed on the packaging.*
Figure 7 (Ef3792bb 0d03 450c B4fa 53fbaae49bd5 10)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
